Emerging data identify molecular subtypes of Long COVID, link pediatric disease to school absenteeism, and define occupational risk factors for persistent symptoms.
A pair of randomized clinical trials published in JAMA investigated whether adding acetaminophen or an opioid analgesic to ibuprofen improves pain relief for children with acute musculoskeletal injuries,...
A phase 3 randomized trial evaluated the efficacy and safety of fremanezumab for preventive treatment of episodic migraine in children and adolescents, addressing a significant evidence gap in pediatric...
The CDC has adopted updated pediatric immunization recommendations following a presidential memorandum requesting a comprehensive scientific assessment of immunization practices in peer countries.
In a prospective cohort of children in California who were prenatally exposed to selective serotonin reuptake inhibitors (SSRIs), investigators examined whether additional exposure to SSRIs via breast milk...
On Friday, the Advisory Committee on Immunization Practices voted 8-3 on major changes to the long-standing universal hepatitis B birth-dose policy, introducing shared decision-making for infants born to...
Federal, professional, and state guidance on COVID-19 vaccination diverge significantly this fall. This guide synthesizes the latest recommendations to help clinicians counsel patients and ensure access.
...
Lumasiran therapy provided durable reductions in urinary and plasma oxalate levels over five years in infants and young children with primary hyperoxaluria type 1, alongside improved nephrocalcinosis and...
